XBRU:SEQUA (Belgium)  
Sequana Medical NV logo

Sequana Medical NV

€ 7.22 (+7.44%) Oct 4
P/E:
At Loss
P/B:
10.34
Market Cap:
€ 171.45M ($ 170.04M)
Enterprise V:
€ 156.30M ($ 155.02M)
Volume:
30.73K
Avg Vol (2M):
3.52K
Also Trade In:
Volume:
30.73K
Market Cap €:
171.45M
Market Cap $:
170.04M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.52K
Enterprise Value €:
156.30M
Enterprise Value $:
155.02M
PB Ratio:
10.34
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
Name Current Vs Industry Vs History
Cash-To-Debt 2.75
Equity-to-Asset 0.42
Debt-to-Equity 0.67
Debt-to-EBITDA -0.36
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -12.31
Distress
Grey
Safe
Beneish M-Score 6.69
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 93.17
9-Day RSI 86.35
14-Day RSI 79.71
6-1 Month Momentum % -7.47
12-1 Month Momentum % -18.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.21
Quick Ratio 2.88
Cash Ratio 2.73
Days Inventory 4858.32
Days Sales Outstanding 40.01
Days Payable 4948.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.8

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.812
EPS (TTM) (€) -1.32
Beta 1.1
Volatility % 32.55
14-Day RSI 79.71
14-Day ATR (€) 0.297062
20-Day SMA (€) 5.869
12-1 Month Momentum % -18.57
52-Week Range (€) 4.86 - 8.5
Shares Outstanding (Mil) 23.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sequana Medical NV Filings

Document Form Filing Date
No Filing Data

Sequana Medical NV Analysis

Share your research